Can Hu

2.5k total citations · 2 hit papers
95 papers, 1.1k citations indexed

About

Can Hu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Can Hu has authored 95 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 24 papers in Oncology. Recurrent topics in Can Hu's work include Gastric Cancer Management and Outcomes (31 papers), Metastasis and carcinoma case studies (14 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). Can Hu is often cited by papers focused on Gastric Cancer Management and Outcomes (31 papers), Metastasis and carcinoma case studies (14 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). Can Hu collaborates with scholars based in China, United States and Japan. Can Hu's co-authors include Xiangdong Cheng, Yuan Li, Jiang‐Jiang Qin, Zhiyuan Xu, Jinyun Dong, Yanqiang Zhang, Hang Lv, Xiangdong Cheng, Zhiyuan Xu and Jingli Xu and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Can Hu

85 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors

2024 87 citations Qing Wei, Jiahui Chen et al. profile →
Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review

2023 85 citations Jinyun Dong, Yuan Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Can Hu China	17	443	308	279	197	137	95	1.1k
Ki‐Yeol Kim South Korea	21	499 1.1×	320 1.0×	260 0.9×	207 1.1×	180 1.3×	75	1.3k
Manabu Ohta Japan	18	304 0.7×	250 0.8×	232 0.8×	242 1.2×	220 1.6×	64	949
Yuqiang Li China	21	511 1.2×	388 1.3×	157 0.6×	252 1.3×	136 1.0×	80	1.1k
Du He China	18	324 0.7×	338 1.1×	216 0.8×	123 0.6×	194 1.4×	89	1.2k
Xiangxing Kong China	16	520 1.2×	290 0.9×	132 0.5×	320 1.6×	125 0.9×	62	1.2k
Jin Roh South Korea	18	348 0.8×	430 1.4×	169 0.6×	171 0.9×	155 1.1×	71	1.2k
Qingxin Xia China	15	166 0.4×	247 0.8×	168 0.6×	126 0.6×	81 0.6×	70	671
Chunlei Zheng China	28	897 2.0×	407 1.3×	335 1.2×	376 1.9×	106 0.8×	96	2.1k
Seungkoo Lee South Korea	18	472 1.1×	224 0.7×	146 0.5×	113 0.6×	211 1.5×	52	1.1k
Ruoxi Yu United States	16	261 0.6×	515 1.7×	326 1.2×	173 0.9×	114 0.8×	42	1.2k

Countries citing papers authored by Can Hu

Since Specialization

Citations

This map shows the geographic impact of Can Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Hu more than expected).

Fields of papers citing papers by Can Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Hu. The network helps show where Can Hu may publish in the future.

Co-authorship network of co-authors of Can Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Can Hu. A scholar is included among the top collaborators of Can Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can Hu. Can Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Can, Jingli Xu, Yanqiang Zhang, et al.. (2025). Inhibition of glutathione peroxidase 4 suppresses gastric cancer peritoneal metastasis via regulation of RCC2 homeostasis. Redox Biology. 80. 103519–103519. 3 indexed citations

Chen, Jiahui, Yingying Sun, Mengge Lyu, et al.. (2024). In-depth metaproteomics analysis of tongue coating for gastric cancer: a multicenter diagnostic research study. Microbiome. 12(1). 6–6. 13 indexed citations

Hu, Can, et al.. (2024). F-box proteins and gastric cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects. International Journal of Medical Sciences. 21(8). 1575–1588. 3 indexed citations

Wang, Yuqi, Jingli Xu, Qianyu Zhao, et al.. (2024). The role of reactive oxygen species in gastric cancer. Cancer Biology and Medicine. 21(9). 1–14. 1 indexed citations

Guan, Xiaoqing, Yichao Wang, Wen-Kai Yu, et al.. (2024). Blocking Ubiquitin‐Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl‐CoA Desaturase. Advanced Science. 11(18). e2307899–e2307899. 39 indexed citations

Hu, Can, et al.. (2024). The Effect of Salmon Calcitonin Adjuvant Treatment for Lumbar Spine Fracture: A Prospective, Randomized, Controlled Trial. Journal of Nutritional Science and Vitaminology. 70(5). 406–410.

Hu, Can, et al.. (2023). Swc4 protects nucleosome-free rDNA, tDNA and telomere loci to inhibit genome instability. DNA repair. 127. 103512–103512.

Hu, Can, et al.. (2023). Conversion therapy for stage IV gastric cancer. Science Bulletin. 68(7). 653–656. 6 indexed citations

Wang, Yi, et al.. (2023). The percentages of signet-ring cells (SRCs) affects the prognosis after radical gastrectomy for advanced gastric cancer. Langenbeck s Archives of Surgery. 408(1). 376–376. 1 indexed citations

10.

Wei, Qing, Yuchao Zhang, Can Hu, et al.. (2023). Spatiotemporal Quantification of HER2-targeting Antibody–Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration. Clinical Cancer Research. 30(5). 984–997. 15 indexed citations

11.

Xu, Handong, Can Hu, Yi Wang, et al.. (2023). Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism. Oncogene. 42(24). 1994–2006. 25 indexed citations

12.

Chen, Ke, Xu Ji, Yuling Tong, et al.. (2023). Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT. Cell Death and Disease. 14(2). 115–115. 26 indexed citations

13.

Li, Shengli, Yuan Li, Zhiyuan Xu, et al.. (2023). Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature Communications. 14(1). 778–778. 24 indexed citations

14.

Pan, Siwei, Can Hu, Yanqiang Zhang, et al.. (2023). A Novel Method for Dynamically Assessing the Prognosis of Patients with pT1 Gastric Cancer: A Large Population-Based Dynamic Prognostic Analysis. Journal of Oncology. 2023. 1–11. 2 indexed citations

15.

Gao, Chen, et al.. (2023). Risk Stratification and Overall Survival Prediction in Advanced Gastric Cancer Patients Based on Whole‐Volume MRI Radiomics. Journal of Magnetic Resonance Imaging. 58(4). 1161–1174. 6 indexed citations

16.

Hu, Can, et al.. (2022). Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 8 indexed citations

17.

Yu, Pengcheng, Weiyang He, Yanqiang Zhang, et al.. (2022). SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. Journal of Oncology. 2022. 1–15. 6 indexed citations

18.

Li, Yuan, Shaowei Mo, Zhiyuan Xu, et al.. (2021). p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier. Pharmacological Research. 165. 105411–105411. 16 indexed citations

19.

Yan, Yanling, Shuai Liu, Can Hu, et al.. (2021). RTKN-1/Rhotekin shields endosome-associated F-actin from disassembly to ensure endocytic recycling. The Journal of Cell Biology. 220(5). 13 indexed citations

20.

Cao, Yangsen, et al.. (2019). Factors associated with de novo metastatic disease in invasive breast cancer: comparison of artificial neural network and logistic regression models. Translational Cancer Research. 8(1). 77–86. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact